Trump presses pharma execs on pricing, U.S. production

Executives from pharmaceutical companies including Johnson & Johnson (NYSE:JNJ), Amgen (NSDQ:AMGN), Merck (NYSE:MRK) and Eli Lilly (NYSE:LLY) met with President Donald Trump today to discuss issues ranging from drug pricing to regulatory approval for pharmaceuticals. The president called on the company execs to increase U.S. production and lower “astronomical” drug prices.

Although Trump doubled down on his calls for the executives to do more to lower drug prices, the meeting seemed to signal a defusing of tensions between the 2 groups. Pharmaceutical stocks tumbled last month after Trump said the companies were “getting away with murder.”

Get the full story at our sister site, Drug Delivery Business News.

The post Trump presses pharma execs on pricing, U.S. production appeared first on MassDevice.

from MassDevice http://ift.tt/2jRLOu3